The Questionable Practice That Permeates Oncology Clinical Trials
Most oncology phase 1 trials use a simplistic, outdated dose-finding technique, and experts agree that change is needed.
General Oncology
FEATURED CONTENT
-
-
Integrative Oncology: Using Evidence-Informed Medicine to Improve Patient Outcomes and Quality of Life
Lifestyle-based integrative treatment approaches — deemed scientifically sound by the field’s proponents — merge conventional and complementary treatments. -
Oral Oncology Parity Laws Don’t Make Medications More Affordable
Out-of-pocket spending remains high for many patients with blood cancers who are receiving tyrosine kinase inhibitors and immunomodulatory drugs. -
The Unexpected Costs of Cancer Treatment: Out-of-Network Billing
The cancer field is not immune to the challenges of out-of-network and surprise billing. -
Preclinical Work on Red Blood Cell-Based Therapies in HPV-Positive Solid Tumors Provides Rationale for Clinical Trials in Humans
A microfluidics platform for engineering activated antigen carrier immunotherapies from red blood cells showed promising preliminary results in a mouse model.
GENERAL ONCOLOGY CANCERS NEWS
AAP Addresses Fertility Preservation for Children With Cancer
Having More Sexual Partners Tied to Increased Odds of Cancer
Belviq, Belviq XR Withdrawn From US Market
Skin Hyperpigmentation Linked to Chemotherapy Drug
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
Want to read more?
Please login or register first to view this content.
Next post in General Oncology
